Raia Drogasil SA (RADL3)

Currency in BRL
114.15
-0.25(-0.22%)
Closed·

RADL3 Earnings

Latest Release
Nov 04, 2025
EPS / Forecast
0.27 / --
Revenue / Forecast
11.26B / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/20250.27/--11.26B/------Free Sign Up
06/20250.23/--10.83B/------Free Sign Up
03/20250.1/--10.05B/------Free Sign Up
12/20240.21/--10.09B/------Free Sign Up
06/2020--/0.35--/4.69B----Free Sign Up
03/20200.44/0.414.95B/5.08B+7.32%-2.56%Free Sign Up
12/20190.46/0.474.74B/4.77B-2.13%-0.63%Free Sign Up
09/20191.44/1.444.69B/4.69B0%0%Free Sign Up
06/20190.46/0.484.23B/4.22B-4.17%+0.24%Free Sign Up
03/20190.32/0.323.95B/3.96B0%-0.25%Free Sign Up

All numbers in BRL

Raia Drogasil SA Earnings Call Summary for Q3/2025

  • RD Saude reported Q3 2025 gross revenue up 12.7% to 12 billion BRL, with EBITDA at 990 million BRL (7.5% margin) and adjusted net income of 420 million BRL (3.3% margin).
  • Digital channel revenue surged 62% to 3 billion BRL, representing 27% penetration, with 97% of deliveries completed within 60 minutes.
  • The company reduced net debt from 3.9% to 3.4% (1.1x EBITDA), generated 648 million BRL in free cash flow, and expanded market share by 80 basis points to 16.8%.
  • RD Saude opened 88 new pharmacy units, reaching 51 million active customers (25% of Brazil's population), and expects significant growth in the GLP-one drug market.
  • CEO Renato Raduane expressed optimism for Q4 and 2026, highlighting substantial digital investments and stating 'We are going to see a very high market share in GLP-one drugs.'
Last Updated: 05/11/2025, 16:48
Read Full Transcript
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.